{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:48:35Z","timestamp":1770504515364,"version":"3.49.0"},"reference-count":52,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Educ Pract Ed"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p>Surfactant replacement therapy has been available for about 25 years, revolutionising neonatal respiratory care after its introduction in the 1980s. Along with antenatal steroids, surfactants improve survival for preterm babies and they are now recommended routinely as early in the course of respiratory distress syndrome (RDS) as possible. Prophylactic treatment, although appearing ideal, exposes some babies who might manage perfectly well on continuous positive airway pressure (CPAP) to intubation and ventilation, which may increase the risk of bronchopulmonary dysplasia. Recent studies attempt to determine the optimal balance between avoiding ventilation by using CPAP and giving surfactant in a timely fashion to babies with RDS. Surfactants are also used for conditions other than RDS, such as meconium aspiration, pulmonary haemorrhage and pneumonia, although the evidence base for their use in these indications is much weaker. Recently, surfactants have been used to deliver steroids directly to the lungs and this seems to be a promising technique worthy of further study. Finally, the quest goes on to develop a synthetic product that can match the effects of animal derived natural surfactants and could be produced at lower cost.<\/jats:p>","DOI":"10.1136\/adc.2008.153023","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T14:05:00Z","timestamp":1242914700000},"page":"78-83","source":"Crossref","is-referenced-by-count":23,"title":["The use of surfactants in 2009: Table 1"],"prefix":"10.1136","volume":"94","author":[{"given":"D G","family":"Sweet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H L","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2009,5,21]]},"reference":[{"key":"2025090700465392000_94.3.78.1","doi-asserted-by":"crossref","unstructured":"Fujiwara T Maeta H Chida S . Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980 12;1:55\u20139.","DOI":"10.1016\/S0140-6736(80)90489-4"},{"key":"2025090700465392000_94.3.78.2","doi-asserted-by":"crossref","unstructured":"Soll RF . Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000;(2):CD000511.","DOI":"10.1002\/14651858.CD000510"},{"key":"2025090700465392000_94.3.78.3","doi-asserted-by":"crossref","unstructured":"Soll RF . Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000;(2):CD001079.","DOI":"10.1002\/14651858.CD000510"},{"key":"2025090700465392000_94.3.78.4","unstructured":"Soll RF . Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2000;(2):CD001149."},{"key":"2025090700465392000_94.3.78.5","unstructured":"BAPM RDS\/Surfactant Guidelines Group. Guidelines for good practice in the management of respiratory distress syndrome. Available from http:\/\/www.bapm.org\/media\/documents\/publications\/rds.pdf (accessed 8 April 2009)."},{"key":"2025090700465392000_94.3.78.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3283"},{"key":"2025090700465392000_94.3.78.7","first-page":"109","article-title":"Recommendations for neonatal surfactant therapy.","volume":"10","author":"Fetus and Newborn Committee, Canadian Paediatric Society (CPS)","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"2025090700465392000_94.3.78.8","doi-asserted-by":"publisher","DOI":"10.1515\/JPM.2007.048"},{"key":"2025090700465392000_94.3.78.9","doi-asserted-by":"crossref","unstructured":"Ho JJ Subramaniam P Henderson-Smart DJ . Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002;(2):CD002271.","DOI":"10.1002\/14651858.CD002271"},{"key":"2025090700465392000_94.3.78.10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2001.00624.x"},{"key":"2025090700465392000_94.3.78.11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-0572-L"},{"key":"2025090700465392000_94.3.78.12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.104.6.1345"},{"key":"2025090700465392000_94.3.78.13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.100.1.e4"},{"key":"2025090700465392000_94.3.78.14","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199709000-00016"},{"key":"2025090700465392000_94.3.78.15","doi-asserted-by":"publisher","DOI":"10.2174\/157339608783565833"},{"key":"2025090700465392000_94.3.78.16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.2.e24"},{"key":"2025090700465392000_94.3.78.17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199808)26:2<129::AID-PPUL10>3.0.CO;2-3"},{"key":"2025090700465392000_94.3.78.18","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050358"},{"key":"2025090700465392000_94.3.78.19","doi-asserted-by":"crossref","unstructured":"Yost CC Soll RF . Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000;(2):CD001456.","DOI":"10.1002\/14651858.CD001456"},{"key":"2025090700465392000_94.3.78.20","doi-asserted-by":"crossref","unstructured":"Soll RF Morley CJ . Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;(2):CD000510.","DOI":"10.1002\/14651858.CD000510"},{"key":"2025090700465392000_94.3.78.21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.6.1006"},{"key":"2025090700465392000_94.3.78.22","first-page":"90","article-title":"Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks\u2019 gestation.","volume":"92","author":"Kattwinkel","year":"1993","journal-title":"Pediatrics"},{"key":"2025090700465392000_94.3.78.23","doi-asserted-by":"crossref","unstructured":"Soll RF Blanco F . Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001;(2):CD000144.","DOI":"10.1002\/14651858.CD000144"},{"key":"2025090700465392000_94.3.78.24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.87.4.505","article-title":"Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with Survanta, a modified bovine surfactant.","volume":"87","author":"Whitsett","year":"1991","journal-title":"Pediatrics"},{"key":"2025090700465392000_94.3.78.25","doi-asserted-by":"publisher","DOI":"10.1007\/BF02113261"},{"key":"2025090700465392000_94.3.78.26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2231"},{"key":"2025090700465392000_94.3.78.27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2183"},{"key":"2025090700465392000_94.3.78.28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0202"},{"key":"2025090700465392000_94.3.78.29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.3.e30"},{"key":"2025090700465392000_94.3.78.30","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0901"},{"key":"2025090700465392000_94.3.78.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072788"},{"key":"2025090700465392000_94.3.78.32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3501"},{"key":"2025090700465392000_94.3.78.33","doi-asserted-by":"publisher","DOI":"10.1159\/000113060"},{"key":"2025090700465392000_94.3.78.34","doi-asserted-by":"crossref","unstructured":"Soll RF . Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev 1999;(2):CD000141.","DOI":"10.1002\/14651858.CD000141"},{"key":"2025090700465392000_94.3.78.35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.2.282"},{"key":"2025090700465392000_94.3.78.36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF03257169","article-title":"Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.","volume":"1","author":"Ainsworth","year":"2002","journal-title":"Am J Respir Med"},{"key":"2025090700465392000_94.3.78.37","doi-asserted-by":"publisher","DOI":"10.1159\/000084879"},{"key":"2025090700465392000_94.3.78.38","doi-asserted-by":"publisher","DOI":"10.1159\/000092869"},{"key":"2025090700465392000_94.3.78.39","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2008.50"},{"key":"2025090700465392000_94.3.78.40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2783"},{"key":"2025090700465392000_94.3.78.41","doi-asserted-by":"publisher","DOI":"10.1159\/000151749"},{"key":"2025090700465392000_94.3.78.42","doi-asserted-by":"crossref","unstructured":"El Shahed AI Dargaville P Ohlsson A . Surfactant for meconium aspiration syndrome in full term\/near term infants. Cochrane Database Syst Rev 2007;(3):CD002054.","DOI":"10.1002\/14651858.CD002054.pub2"},{"key":"2025090700465392000_94.3.78.43","doi-asserted-by":"publisher","DOI":"10.1159\/000143394"},{"key":"2025090700465392000_94.3.78.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(06)80131-9"},{"key":"2025090700465392000_94.3.78.45","doi-asserted-by":"crossref","unstructured":"Aziz A Ohlsson A . Surfactant for pulmonary hemorrhage in neonates. Cochrane Database Syst Rev 2008;(2):CD005254.","DOI":"10.1002\/14651858.CD005254.pub2"},{"key":"2025090700465392000_94.3.78.46","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.5.957"},{"key":"2025090700465392000_94.3.78.47","doi-asserted-by":"publisher","DOI":"10.1080\/080352502320777397"},{"key":"2025090700465392000_94.3.78.48","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.4.470"},{"key":"2025090700465392000_94.3.78.49","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1973"},{"key":"2025090700465392000_94.3.78.50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2007.00617.x"},{"key":"2025090700465392000_94.3.78.51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211103"},{"key":"2025090700465392000_94.3.78.52","doi-asserted-by":"publisher","DOI":"10.1159\/000083370"}],"container-title":["Archives of disease in childhood - Education &amp; practice edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.2008.153023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:47:07Z","timestamp":1757231227000},"score":1,"resource":{"primary":{"URL":"https:\/\/ep.bmj.com\/lookup\/doi\/10.1136\/adc.2008.153023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,21]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,5,21]]},"published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1136\/adc.2008.153023"],"URL":"https:\/\/doi.org\/10.1136\/adc.2008.153023","relation":{},"ISSN":["1743-0585","1743-0593"],"issn-type":[{"value":"1743-0585","type":"print"},{"value":"1743-0593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,21]]}}}